Novel treatment modalities for nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently associated with an increased risk of death due to cardiovascular and liver diseases. Over the past 5 years, numerous ad...
Saved in:
| Published in | Trends in endocrinology and metabolism Vol. 21; no. 11; pp. 668 - 675 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Cambridge, MA
Elsevier Ltd
01.11.2010
Cell Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1043-2760 1879-3061 1879-3061 |
| DOI | 10.1016/j.tem.2010.08.003 |
Cover
| Abstract | Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently associated with an increased risk of death due to cardiovascular and liver diseases. Over the past 5 years, numerous advances in understanding its pathogenesis have been made, providing a rationale for translation of this information into clinical trials. Although the optimum therapy is still awaited, there is strong evidence to support the use of vitamin E in selected subjects. Many other potential therapeutic options are now available. In this paper, we review the status of both current and emerging therapeutic strategies for patients with NASH. |
|---|---|
| AbstractList | Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently associated with an increased risk of death due to cardiovascular and liver diseases. Over the past 5 years, numerous advances in understanding its pathogenesis have been made, providing a rationale for translation of this information into clinical trials. Although the optimum therapy is still awaited, there is strong evidence to support the use of vitamin E in selected subjects. Many other potential therapeutic options are now available. In this paper, we review the status of both current and emerging therapeutic strategies for patients with NASH. Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently associated with an increased risk of death due to cardiovascular and liver diseases. Over the past 5 years, numerous advances in understanding its pathogenesis have been made, providing a rationale for translation of this information into clinical trials. Although the optimum therapy is still awaited, there is strong evidence to support the use of vitamin E in selected subjects. Many other potential therapeutic options are now available. In this paper, we review the status of both current and emerging therapeutic strategies for patients with NASH.Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently associated with an increased risk of death due to cardiovascular and liver diseases. Over the past 5 years, numerous advances in understanding its pathogenesis have been made, providing a rationale for translation of this information into clinical trials. Although the optimum therapy is still awaited, there is strong evidence to support the use of vitamin E in selected subjects. Many other potential therapeutic options are now available. In this paper, we review the status of both current and emerging therapeutic strategies for patients with NASH. |
| Author | Satapathy, Sanjaya K. Sanyal, Arun J |
| Author_xml | – sequence: 1 givenname: Sanjaya K. surname: Satapathy fullname: Satapathy, Sanjaya K. organization: Division of Gastroenterology, Long Island Jewish Medical Center, North Shore University-Long Island Jewish Health System, 270-05 76th Avenue, New Hyde Park, NY 11040, USA – sequence: 2 givenname: Arun J surname: Sanyal fullname: Sanyal, Arun J email: asanyal@mcvh-vcu.edu organization: Division of Gastroenterology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Virginia, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23382465$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20880717$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEUhoNU7If-AG9kbsSrWU8-JslSEKRULRS9UK9DJnOGZs1M1iRb6L9vhl0VCra5SQ487zm8b84pOZrjjIS8prCiQOX7zargtGJQa9ArAP6MnFCt1i0HSY_qGwRvmZJwTE5z3gBQoWn3ghwz0BoUVSfk_Gu8xdCUhLZMOJdmioMNvnjMzRhTUyfa4OJNDN41uVQq3uDWlkrkl-T5aEPGV4f7jPz8dPnj4kt7_e3z1cXH69YJrUor64FBDG7QqutHZGAR6CCQrxVKxxG7DgbZSe16KnrRd9I6ZqVWjDqnBT8j7_Z9tyn-3mEuZvLZYQh2xrjLRkkGnDIBlXxzIHf9hIPZJj_ZdGf--K3A2wNgs7NhTHZ2Pv_jONdMyK5ydM-5FHNOOP5FKJgle7MxNXuzZG9Am5p91agHGudLTSrOJVkfHlWe75VYU7z1mEx2HmeHg0_oihmif1T94YHaBT_7au8X3mHexF2qf5gNNZkZMN-XrViWgkJdCM4Xs-v_N3hi-D2XlMUw |
| CitedBy_id | crossref_primary_10_3748_wjg_v20_i34_12182 crossref_primary_10_1007_s10620_019_05716_1 crossref_primary_10_3109_13697137_2014_933408 crossref_primary_10_1002_hep_29230 crossref_primary_10_2337_db18_0035 crossref_primary_10_1517_14656566_2011_587123 crossref_primary_10_1097_MEG_0000000000001590 crossref_primary_10_1016_j_lfs_2020_118615 crossref_primary_10_1111_j_1477_2574_2011_00380_x crossref_primary_10_1152_ajpgi_00225_2013 crossref_primary_10_1159_000365415 crossref_primary_10_1038_oby_2012_31 crossref_primary_10_1210_er_2012_1009 crossref_primary_10_2119_molmed_2011_00083 crossref_primary_10_1016_j_jhep_2015_05_012 crossref_primary_10_1007_s00281_013_0399_z crossref_primary_10_1016_j_jhep_2011_04_007 crossref_primary_10_1590_S0103_05822013000400016 crossref_primary_10_1016_j_atherosclerosis_2011_08_041 crossref_primary_10_1016_j_dld_2014_01_156 crossref_primary_10_1021_acs_biochem_2c00583 crossref_primary_10_1089_ars_2016_6776 crossref_primary_10_1002_hep_24213 crossref_primary_10_1016_j_biopha_2022_113764 crossref_primary_10_1124_mol_113_088039 crossref_primary_10_1016_j_cgh_2012_03_011 crossref_primary_10_1016_j_tem_2013_05_009 crossref_primary_10_4065_mcp_2011_0318 crossref_primary_10_1074_jbc_M112_397133 crossref_primary_10_1155_2012_934396 |
| Cites_doi | 10.3346/jkms.1995.10.6.414 10.1056/NEJMra041001 10.1002/hep.20701 10.1053/jlts.2001.23011 10.1002/hep.20092 10.1111/j.1572-0241.1998.00139.x 10.1016/j.jhep.2007.02.013 10.1016/j.jhep.2005.06.008 10.1002/hep.23521 10.1002/hep.21661 10.1002/hep.20251 10.1016/S0016-5085(09)63900-7 10.1381/096089206776944904 10.1097/00005176-200401000-00012 10.1056/NEJMoa0804748 10.1023/B:DDAS.0000043364.75898.c8 10.1002/hep.20420 10.1111/j.1572-0241.2005.41583.x 10.3748/wjg.14.1598 10.1056/NEJMoa022207 10.1016/S0168-8278(97)80287-5 10.1002/hep.23239 10.1111/j.1751-2980.2008.00323.x 10.1007/s00592-008-0067-2 10.1111/j.1572-0241.2004.40064.x 10.1016/j.cgh.2006.09.025 10.1001/jama.1984.03340410049031 10.1111/j.1572-0241.2005.41334.x 10.7326/0003-4819-142-1-200501040-00110 10.1161/CIRCULATIONAHA.106.624890 10.1016/j.cld.2009.07.006 10.1016/S1262-3636(08)74603-2 10.1007/s11695-007-9086-2 10.1111/j.1365-2036.2006.03161.x 10.1097/MEG.0b013e32832e2baf 10.1002/hep.1840160426 10.1053/j.gastro.2007.03.057 10.1002/hep.510300604 10.1002/hep.23276 10.1016/0014-5793(92)81290-3 10.1046/j.1365-2036.2001.01083.x 10.2174/156652410790963321 10.1056/NEJMoa060326 10.1002/hep.20466 10.1111/j.1440-1746.2005.04233.x 10.1007/BF03401914 10.1046/j.1467-789X.2002.00078.x 10.1053/j.gastro.2008.06.047 10.2174/157016110793563870 10.1152/ajpgi.00133.2007 10.1159/000282091 10.1172/JCI34827 10.1016/j.amjmed.2009.12.006 10.1016/S0016-5085(99)70506-8 10.1111/j.1572-0241.2004.40220.x 10.1053/jhep.2003.50316 10.1093/ajcn/86.2.285 10.1161/CIRCULATIONAHA.106.171016 10.1111/j.1572-0241.2003.08699.x 10.1055/s-0028-1091983 10.1016/j.jhep.2009.03.019 10.1016/S1726-4901(08)70168-0 10.1111/j.1572-0241.2006.00419.x 10.1111/j.1365-2036.2004.01888.x 10.1002/hep.23270 10.1111/j.1440-1746.2006.04756.x 10.1172/JCI13505 10.1016/j.cgh.2008.12.015 10.1053/j.gastro.2005.03.084 10.1074/jbc.R800012200 10.1016/S1542-3565(04)00457-4 10.1007/s10620-006-9703-2 10.1172/JCI1325 10.1038/nrd2619 10.1203/01.PDR.0000153672.43030.75 10.1136/gut.2008.151977 10.1016/S0022-3476(00)05040-X 10.1136/gut.2003.027581 10.1111/j.1445-5994.2006.01295.x 10.1381/096089204772787284 10.1016/j.jada.2007.05.009 10.1016/j.surg.2003.10.003 10.3748/wjg.15.942 10.1056/NEJMoa0907929 10.1185/030079908X253870 10.7326/0003-4819-115-12-956 10.1002/hep.22724 10.1002/14651858.CD007340.pub2 10.1053/j.gastro.2006.02.024 10.1001/archsurg.133.1.84 10.3949/ccjm.73.4.382 10.1001/jama.2008.600 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2010 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.tem.2010.08.003 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-3061 |
| EndPage | 675 |
| ExternalDocumentID | 20880717 23382465 10_1016_j_tem_2010_08_003 S1043276010001335 1_s2_0_S1043276010001335 |
| Genre | Evaluation Studies Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 3O- 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K WUQ XFW Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RCE RIG AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c487t-66660d4dcd875bfe20ae01d4e397e6c3ee550d6568cb14b4b56ac2a68721cc843 |
| IEDL.DBID | AIKHN |
| ISSN | 1043-2760 1879-3061 |
| IngestDate | Fri Sep 05 09:49:15 EDT 2025 Thu Apr 03 04:55:28 EDT 2025 Mon Jul 21 09:12:01 EDT 2025 Thu Apr 24 23:09:25 EDT 2025 Tue Jul 01 04:29:30 EDT 2025 Fri Feb 23 02:26:39 EST 2024 Sun Feb 23 10:19:06 EST 2025 Tue Aug 26 16:37:09 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Treatment |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2010 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c487t-66660d4dcd875bfe20ae01d4e397e6c3ee550d6568cb14b4b56ac2a68721cc843 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
| PMID | 20880717 |
| PQID | 762031240 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_762031240 pubmed_primary_20880717 pascalfrancis_primary_23382465 crossref_primary_10_1016_j_tem_2010_08_003 crossref_citationtrail_10_1016_j_tem_2010_08_003 elsevier_sciencedirect_doi_10_1016_j_tem_2010_08_003 elsevier_clinicalkeyesjournals_1_s2_0_S1043276010001335 elsevier_clinicalkey_doi_10_1016_j_tem_2010_08_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-11-01 |
| PublicationDateYYYYMMDD | 2010-11-01 |
| PublicationDate_xml | – month: 11 year: 2010 text: 2010-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cambridge, MA |
| PublicationPlace_xml | – name: Cambridge, MA – name: United States |
| PublicationTitle | Trends in endocrinology and metabolism |
| PublicationTitleAlternate | Trends Endocrinol Metab |
| PublicationYear | 2010 |
| Publisher | Elsevier Ltd Cell Press |
| Publisher_xml | – name: Elsevier Ltd – name: Cell Press |
| References | Poirier (bib0080) 2006; 113 Abdelmalek (bib0370) 2009; 50 Argo (bib0055) 2009; 51 Dallal (bib0225) 2004; 14 Ekstedt (bib0480) 2007; 47 Brunt (bib0035) 2009; 49 Zivkovic (bib0095) 2007; 86 136, P244.[Abstract T1013] Song (bib0365) 2007; 293 Erlichman (bib0180) 2002; 3 Cotler (bib0165) 2004; 49 Miller (bib0355) 2005; 142 Ratziu (bib0260) 2010; 51 Lin H.Z. Promrat (bib0100) 2010; 51 Kantartzis (bib0105) 2009; 58 Sanyal (bib0240) 2010; 362 Perelas A. Klonoff (bib0315) 2008; 24 Browning (bib0005) 2004; 40 115, 956–61. Kashani (bib0485) 2006; 114 Yokohama (bib0440) 2004; 40 NIH conference. (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. (2006)–(2007) (2007) American Diabetes Association Nutrition Recommendations, issues for practice translation. Castera (bib0065) 2008; 34 J Harrison (bib0340) 2003; 98 Angulo (bib0030) 1999; 30 Neuschwander-Tetri (bib0075) 2009; 13 Flora (bib0375) 1998; 93 Baba (bib0125) 2006; 21 Satapathy (bib0420) 2004; 99 Uygun (bib0280) 2004; 19 Georgescu, Georgescu (bib0500) 2007; 16 Ratziu (bib0045) 2005; 128 Lavine (bib0350) 2000; 136 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, executive summary. (1998) Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Lindor (bib0395) 2004; 39 (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Nar, Gedik (bib0250) 2009; 46 Loguercio (bib0380) 2007; 52 Wieckowska, Feldstein (bib0025) 2008; 28 Aithal (bib0255) 2008; 135 Rodrigues (bib0385) 1998; 101 Rodrigues (bib0390) 1998; 4 Barker (bib0205) 2006; 101 Wylie-Rosett J. (2010) Effects of lipid-lowering drugs on adiponectin. 107, 1296–304 Park (bib0160) 1995; 10 Hasegawa (bib0345) 2001; 15 Elder, Wolfe (bib0190) 2007; 132 Csendes (bib0210) 2006; 16 Kunos (bib0455) 2008 Nov 28; 283 Nobili (bib0115) 2006; 24 Osei-Hyiaman (bib0460) 2008; 118 Matteoni (bib0020) 1999; 116 Ueno (bib0155) 1997; 27 Hickman (bib0140) 2004; 53 Mudaliar, Henry (bib0305) 2010; 123 in patients with non-alcoholic steatohepatitis. Parola (bib0325) 1992; 308 Parola (bib0320) 1992; 16 Angulo (bib0015) 2010; 51 Kral (bib0235) 2004; 135 Suzuki (bib0135) 2005; 43 Brolin (bib0230) 1998; 133 Salehi, D’Alessio (bib0495) 2006; 73 Alwayn (bib0465) 2005; 57 68, 899–917 Chen (bib0110) 2008; 71 Thomas (bib0405) 2008; 7 Kugelmas (bib0150) 2003; 38 Contos (bib0060) 2001; 7 Belfort (bib0265) 2006; 355 Ratziu V. Omer (bib0245) 2010; 22 Zhou (bib0285) 2001; 108 Dufour (bib0335) 2006; 4 Bugianesi (bib0270) 2005; 100 Georgescu (bib0435) 2008; 25 (2004) Metformin reverses fatty liver disease in obese., leptin-deficient mice. Nat. Med. 2000; 6, 998–1003 Satapathy (bib0430) 2007; 22 Lutchman (bib0300) 2007; 46 Mathurin (bib0215) 2006; 130 (2009) A multicentric, double-blind., randomized placebo-controlled trial of high dose Ursodeoxycholic Feb 25 [Epub ahead of print] Foster (bib0170) 2003; 22 Sacks (bib0175) 2009; 360 Huang (bib0130) 2005; 100 Vuppalanchi (bib0050) 2009; 7 Estep (bib0070) 2010; 10 Sanyal (bib0275) 2004; 2 Adams (bib0425) 2004; 99 Yki-Järvinen (bib0490) 2004; 351 Sesso (bib0360) 2008; 300 Trauner (bib0410) 2010; 28 Kleiner (bib0040) 2005; 41 Dixon (bib0195) 2004; 39 Yakaryilmaz (bib0330) 2007; 37 Vajro (bib0145) 2004; 38 Chavez-Tapia N.C. Wang (bib0120) 2008; 14 Georgescu (bib0450) 2009; 15 1, CD007340 Liu (bib0200) 2007; 17 Schade (bib0415) 1990; 31 Fan (bib0010) 2008; 9 Kesäniemi, Grundy (bib0470) 1984; 251 Mudaliar (10.1016/j.tem.2010.08.003_bib0305) 2010; 123 Matteoni (10.1016/j.tem.2010.08.003_bib0020) 1999; 116 Suzuki (10.1016/j.tem.2010.08.003_bib0135) 2005; 43 Yki-Järvinen (10.1016/j.tem.2010.08.003_bib0490) 2004; 351 Fan (10.1016/j.tem.2010.08.003_bib0010) 2008; 9 Miller (10.1016/j.tem.2010.08.003_bib0355) 2005; 142 Kleiner (10.1016/j.tem.2010.08.003_bib0040) 2005; 41 Ueno (10.1016/j.tem.2010.08.003_bib0155) 1997; 27 Csendes (10.1016/j.tem.2010.08.003_bib0210) 2006; 16 Ratziu (10.1016/j.tem.2010.08.003_bib0260) 2010; 51 Omer (10.1016/j.tem.2010.08.003_bib0245) 2010; 22 Trauner (10.1016/j.tem.2010.08.003_bib0410) 2010; 28 Erlichman (10.1016/j.tem.2010.08.003_bib0180) 2002; 3 Promrat (10.1016/j.tem.2010.08.003_bib0100) 2010; 51 Elder (10.1016/j.tem.2010.08.003_bib0190) 2007; 132 Parola (10.1016/j.tem.2010.08.003_bib0325) 1992; 308 Sacks (10.1016/j.tem.2010.08.003_bib0175) 2009; 360 Alwayn (10.1016/j.tem.2010.08.003_bib0465) 2005; 57 Rodrigues (10.1016/j.tem.2010.08.003_bib0385) 1998; 101 Lindor (10.1016/j.tem.2010.08.003_bib0395) 2004; 39 Osei-Hyiaman (10.1016/j.tem.2010.08.003_bib0460) 2008; 118 Liu (10.1016/j.tem.2010.08.003_bib0200) 2007; 17 Georgescu (10.1016/j.tem.2010.08.003_bib0450) 2009; 15 Contos (10.1016/j.tem.2010.08.003_bib0060) 2001; 7 10.1016/j.tem.2010.08.003_bib0290 Flora (10.1016/j.tem.2010.08.003_bib0375) 1998; 93 Brunt (10.1016/j.tem.2010.08.003_bib0035) 2009; 49 Vajro (10.1016/j.tem.2010.08.003_bib0145) 2004; 38 Angulo (10.1016/j.tem.2010.08.003_bib0015) 2010; 51 Cotler (10.1016/j.tem.2010.08.003_bib0165) 2004; 49 Kunos (10.1016/j.tem.2010.08.003_bib0455) 2008; 283 Angulo (10.1016/j.tem.2010.08.003_bib0030) 1999; 30 Brolin (10.1016/j.tem.2010.08.003_bib0230) 1998; 133 Nar (10.1016/j.tem.2010.08.003_bib0250) 2009; 46 Castera (10.1016/j.tem.2010.08.003_bib0065) 2008; 34 Uygun (10.1016/j.tem.2010.08.003_bib0280) 2004; 19 Poirier (10.1016/j.tem.2010.08.003_bib0080) 2006; 113 Abdelmalek (10.1016/j.tem.2010.08.003_bib0370) 2009; 50 Parola (10.1016/j.tem.2010.08.003_bib0320) 1992; 16 Wang (10.1016/j.tem.2010.08.003_bib0120) 2008; 14 Zhou (10.1016/j.tem.2010.08.003_bib0285) 2001; 108 Baba (10.1016/j.tem.2010.08.003_bib0125) 2006; 21 Huang (10.1016/j.tem.2010.08.003_bib0130) 2005; 100 Lutchman (10.1016/j.tem.2010.08.003_bib0300) 2007; 46 Dufour (10.1016/j.tem.2010.08.003_bib0335) 2006; 4 Kesäniemi (10.1016/j.tem.2010.08.003_bib0470) 1984; 251 Georgescu (10.1016/j.tem.2010.08.003_bib0500) 2007; 16 10.1016/j.tem.2010.08.003_bib0475 Kral (10.1016/j.tem.2010.08.003_bib0235) 2004; 135 Salehi (10.1016/j.tem.2010.08.003_bib0495) 2006; 73 Yakaryilmaz (10.1016/j.tem.2010.08.003_bib0330) 2007; 37 Zivkovic (10.1016/j.tem.2010.08.003_bib0095) 2007; 86 Belfort (10.1016/j.tem.2010.08.003_bib0265) 2006; 355 Thomas (10.1016/j.tem.2010.08.003_bib0405) 2008; 7 Adams (10.1016/j.tem.2010.08.003_bib0425) 2004; 99 Ekstedt (10.1016/j.tem.2010.08.003_bib0480) 2007; 47 Satapathy (10.1016/j.tem.2010.08.003_bib0420) 2004; 99 Lavine (10.1016/j.tem.2010.08.003_bib0350) 2000; 136 Ratziu (10.1016/j.tem.2010.08.003_bib0045) 2005; 128 10.1016/j.tem.2010.08.003_bib0185 Georgescu (10.1016/j.tem.2010.08.003_bib0435) 2008; 25 Dallal (10.1016/j.tem.2010.08.003_bib0225) 2004; 14 Hickman (10.1016/j.tem.2010.08.003_bib0140) 2004; 53 Bugianesi (10.1016/j.tem.2010.08.003_bib0270) 2005; 100 Barker (10.1016/j.tem.2010.08.003_bib0205) 2006; 101 Estep (10.1016/j.tem.2010.08.003_bib0070) 2010; 10 10.1016/j.tem.2010.08.003_bib0220 Satapathy (10.1016/j.tem.2010.08.003_bib0430) 2007; 22 Kashani (10.1016/j.tem.2010.08.003_bib0485) 2006; 114 Kugelmas (10.1016/j.tem.2010.08.003_bib0150) 2003; 38 Kantartzis (10.1016/j.tem.2010.08.003_bib0105) 2009; 58 Yokohama (10.1016/j.tem.2010.08.003_bib0440) 2004; 40 Neuschwander-Tetri (10.1016/j.tem.2010.08.003_bib0075) 2009; 13 Harrison (10.1016/j.tem.2010.08.003_bib0340) 2003; 98 Hasegawa (10.1016/j.tem.2010.08.003_bib0345) 2001; 15 Dixon (10.1016/j.tem.2010.08.003_bib0195) 2004; 39 Mathurin (10.1016/j.tem.2010.08.003_bib0215) 2006; 130 Sesso (10.1016/j.tem.2010.08.003_bib0360) 2008; 300 Nobili (10.1016/j.tem.2010.08.003_bib0115) 2006; 24 Song (10.1016/j.tem.2010.08.003_bib0365) 2007; 293 Foster (10.1016/j.tem.2010.08.003_bib0170) 2003; 22 Browning (10.1016/j.tem.2010.08.003_bib0005) 2004; 40 Loguercio (10.1016/j.tem.2010.08.003_bib0380) 2007; 52 Argo (10.1016/j.tem.2010.08.003_bib0055) 2009; 51 Park (10.1016/j.tem.2010.08.003_bib0160) 1995; 10 Vuppalanchi (10.1016/j.tem.2010.08.003_bib0050) 2009; 7 Chen (10.1016/j.tem.2010.08.003_bib0110) 2008; 71 10.1016/j.tem.2010.08.003_bib0085 Sanyal (10.1016/j.tem.2010.08.003_bib0275) 2004; 2 Schade (10.1016/j.tem.2010.08.003_bib0415) 1990; 31 Rodrigues (10.1016/j.tem.2010.08.003_bib0390) 1998; 4 10.1016/j.tem.2010.08.003_bib0400 Wieckowska (10.1016/j.tem.2010.08.003_bib0025) 2008; 28 Sanyal (10.1016/j.tem.2010.08.003_bib0240) 2010; 362 Aithal (10.1016/j.tem.2010.08.003_bib0255) 2008; 135 10.1016/j.tem.2010.08.003_bib0090 Klonoff (10.1016/j.tem.2010.08.003_bib0315) 2008; 24 |
| References_xml | – reference: Lin H.Z., – volume: 28 start-page: 220 year: 2010 end-page: 224 ident: bib0410 article-title: Bile acids as regulators of hepatic lipid and glucose metabolism publication-title: Dig Dis. – volume: 135 start-page: 48 year: 2004 end-page: 58 ident: bib0235 article-title: Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis publication-title: Surgery – volume: 10 start-page: 166 year: 2010 end-page: 172 ident: bib0070 article-title: Non-invasive diagnostic tests for non-alcoholic fatty liver disease publication-title: Curr. Mol. Med. – volume: 355 start-page: 2297 year: 2006 end-page: 2307 ident: bib0265 article-title: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N. Engl. J. Med. – volume: 136 start-page: 734 year: 2000 end-page: 738 ident: bib0350 article-title: Vitamin E treatment of nonalcoholic steatohepatitis in children, a pilot study publication-title: J Pediatr. – volume: 15 start-page: 942 year: 2009 end-page: 954 ident: bib0450 article-title: Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatit publication-title: World J. Gastroenterol. – volume: 28 start-page: 386 year: 2008 end-page: 395 ident: bib0025 article-title: Diagnosis of nonalcoholic fatty liver disease, invasive versus noninvasive publication-title: Semin. Liver Dis. – volume: 7 start-page: 363 year: 2001 end-page: 733 ident: bib0060 article-title: Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis publication-title: Liver Transpl. – reference: in patients with non-alcoholic steatohepatitis. – volume: 39 start-page: 1647 year: 2004 end-page: 1654 ident: bib0195 article-title: Nonalcoholic fatty liver disease. Improvement in liver histological analysis with weight loss publication-title: Hepatology – volume: 25 start-page: 1141 year: 2008 end-page: 1174 ident: bib0435 article-title: Angiotensin receptor blockers in the treatment of NASH/NAFLD, could they be a first-class option? publication-title: Ther. – volume: 293 start-page: G894 year: 2007 end-page: 902 ident: bib0365 article-title: Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis publication-title: Am. J. Physiol. Gastrointest Liver Physiol. – volume: 251 start-page: 2241 year: 1984 end-page: 2246 ident: bib0470 article-title: Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man publication-title: JAMA – volume: 128 start-page: 1898 year: 2005 end-page: 1906 ident: bib0045 article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 135 start-page: 1176 year: 2008 end-page: 1184 ident: bib0255 article-title: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 71 start-page: 551 year: 2008 end-page: 558 ident: bib0110 article-title: Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease publication-title: J. Chin. Med. Assoc. – volume: 3 start-page: 273 year: 2002 end-page: 287 ident: bib0180 article-title: Physical activity and its impact on health outcomes. Paper 2. Prevention of unhealthy weight gain and obesity by physical activity, an analysis of the evidence publication-title: Obes. Rev. – volume: 100 start-page: 1072 year: 2005 end-page: 1081 ident: bib0130 article-title: One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis, a pilot study publication-title: Am. J. Gastroenterol. – volume: 38 start-page: 413 year: 2003 end-page: 419 ident: bib0150 article-title: Cytokines and NASH, a pilot study of the effects of lifestyle modification and vitamin E publication-title: Hepatology – volume: 123 start-page: S19 year: 2010 end-page: 27 ident: bib0305 article-title: Effects of incretin hormones on beta-cell mass and function, body weight., and hepatic and myocardial function publication-title: Am. J. Med. – reference: . (2004) Metformin reverses fatty liver disease in obese., leptin-deficient mice. Nat. Med. 2000; 6, 998–1003 – reference: . (2009) A multicentric, double-blind., randomized placebo-controlled trial of high dose Ursodeoxycholic – volume: 114 start-page: 2788 year: 2006 end-page: 2797 ident: bib0485 article-title: Risks associated with statin therapy publication-title: Circulation – volume: 49 start-page: 1563 year: 2004 end-page: 1568 ident: bib0165 article-title: Hepatic decompensation after gastric bypass surgery for severe obesity publication-title: Dig Dis. Sci. – volume: 24 start-page: 275 year: 2008 end-page: 286 ident: bib0315 article-title: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years publication-title: Curr. Med. Res. Opin. – volume: 4 start-page: 1537 year: 2006 end-page: 1543 ident: bib0335 article-title: Swiss Association for the Study of the publication-title: Clin. Gastroenterol. Hepatol. – volume: 15 start-page: 1667 year: 2001 end-page: 1672 ident: bib0345 article-title: Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis, a pilot study publication-title: Aliment Pharmacol. Ther. – reference: 136, P244.[Abstract T1013] – volume: 113 start-page: 898 year: 2006 end-page: 918 ident: bib0080 article-title: American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease, pathophysiology, evaluation, and effect of weight loss, an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition., Physical Activity., and Metabolism publication-title: Circulation – volume: 40 start-page: 1222 year: 2004 end-page: 1225 ident: bib0440 article-title: Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis publication-title: Hepatology – reference: 68, 899–917 – reference: 107, 1296–304 – reference: Chavez-Tapia N.C., – volume: 37 start-page: 229 year: 2007 end-page: 235 ident: bib0330 article-title: Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis, results of a pilot study publication-title: Intern. Med. J. – volume: 27 start-page: 103 year: 1997 end-page: 107 ident: bib0155 article-title: Therapeutic effects of restricted diet and exercise in obese patients with fatty liver publication-title: J. Hepatol. – volume: 10 start-page: 414 year: 1995 end-page: 421 ident: bib0160 article-title: Effect of weight control on hepatic abnormalities in obese patients with fatty liver publication-title: J. Korean Med. Sci. – volume: 53 start-page: 413 year: 2004 end-page: 419 ident: bib0140 article-title: Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase., fasting insulin., and quality of life publication-title: Gut. – volume: 46 start-page: 113 year: 2009 end-page: 118 ident: bib0250 article-title: The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease publication-title: Acta. Diabetol. – volume: 50 start-page: 1818 year: 2009 end-page: 1826 ident: bib0370 article-title: Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial publication-title: Hepatology – volume: 49 start-page: 809 year: 2009 end-page: 820 ident: bib0035 article-title: Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD), a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network publication-title: Hepatology – volume: 101 start-page: 368 year: 2006 end-page: 373 ident: bib0205 article-title: Non-alcoholic steatohepatitis, effect of Roux-en-Y gastric bypass surgery publication-title: Am. J. Gastroenterol. – volume: 99 start-page: 1946 year: 2004 end-page: 1952 ident: bib0420 article-title: Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical., biochemical., and metabolic parameters of patients with nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. – volume: 9 start-page: 63 year: 2008 end-page: 67 ident: bib0010 article-title: Impact of non-alcoholic fatty liver disease on accelerated metabolic complications publication-title: J. Dig Dis. – reference: . (2006)–(2007) (2007) American Diabetes Association Nutrition Recommendations, issues for practice translation. – volume: 142 start-page: 37 year: 2005 end-page: 46 ident: bib0355 article-title: Meta-analysis, high-dosage vitamin E supplementation may increase all-cause mortality publication-title: Ann. Intern. Med. – volume: 43 start-page: 1060 year: 2005 end-page: 1066 ident: bib0135 article-title: Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease publication-title: J. Hepatol. – reference: . (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. – volume: 73 start-page: 382 year: 2006 end-page: 389 ident: bib0495 article-title: New therapies for type 2 diabetes based on glucagon-like peptide 1 publication-title: Cleve Clin J Med. – volume: 22 start-page: 2082 year: 2003 end-page: 2090 ident: bib0170 article-title: A randomized trial of a low-carbohydrate diet for obesity publication-title: N. Engl. J. Med. – volume: 16 start-page: 39 year: 2007 end-page: 46 ident: bib0500 article-title: Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study publication-title: J Gastrointestin Liver Dis. – volume: 22 start-page: 18 year: 2010 end-page: 23 ident: bib0245 article-title: Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease publication-title: Eur. J. Gastroenterol. Hepatol. – volume: 108 start-page: 1167 year: 2001 end-page: 1174 ident: bib0285 article-title: Role of AMP-activated protein kinase in mechanism of metformin action publication-title: J. Clin. Invest. – volume: 40 start-page: 1387 year: 2004 end-page: 1395 ident: bib0005 article-title: Prevalence of hepatic steatosis in an urban population in the United States, impact of ethnicity publication-title: Hepatology – volume: 132 start-page: 2253 year: 2007 end-page: 2271 ident: bib0190 article-title: Bariatric surgery, a review of procedures and outcomes publication-title: Gastroenterology – volume: 38 start-page: 48 year: 2004 end-page: 55 ident: bib0145 article-title: Vitamin E treatment in pediatric obesity-related liver disease, a randomized study publication-title: J. Pediatr. Gastroenterol. Nutr. – volume: 30 start-page: 1356 year: 1999 end-page: 1362 ident: bib0030 article-title: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis publication-title: Hepatology – volume: 300 start-page: 2123 year: 2008 end-page: 2133 ident: bib0360 article-title: Vitamins E and C in the prevention of cardiovascular disease in men, the Physicians’ Health Study II randomized controlled trial publication-title: JAMA – volume: 13 start-page: 649 year: 2009 end-page: 665 ident: bib0075 article-title: Lifestyle modification as the primary treatment of NASH publication-title: Clin. Liver Dis. – reference: Wylie-Rosett J., – reference: . (2010) Effects of lipid-lowering drugs on adiponectin. – volume: 351 start-page: 1106 year: 2004 end-page: 1118 ident: bib0490 article-title: Thiazolidinediones publication-title: N Engl J Med. – volume: 133 start-page: 84 year: 1998 end-page: 88 ident: bib0230 article-title: Unsuspected cirrhosis discovered during elective obesity operations publication-title: Arch. Surg. – volume: 98 start-page: 2485 year: 2003 end-page: 2490 ident: bib0340 article-title: Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. – volume: 31 start-page: 171 year: 1990 end-page: 181 ident: bib0415 article-title: Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor publication-title: Circ. Shock – volume: 283 start-page: 33021 year: 2008 Nov 28 end-page: 33025 ident: bib0455 article-title: Endocannabinoids and the control of energy homeostasis publication-title: J. Biol. Chem. – volume: 57 start-page: 445 year: 2005 end-page: 452 ident: bib0465 article-title: Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease publication-title: Pediatr. Res. – reference: Feb 25 [Epub ahead of print] – volume: 51 start-page: 373 year: 2010 end-page: 375 ident: bib0015 article-title: Long-term mortality in nonalcoholic fatty liver disease, is liver histology of any prognostic significance? publication-title: Hepatology – volume: 34 start-page: 674 year: 2008 end-page: 679 ident: bib0065 article-title: Non-invasive diagnosis of steatosis and fibrosis publication-title: Diabetes Metab – reference: 1, CD007340 – volume: 2 start-page: 1107 year: 2004 end-page: 1115 ident: bib0275 article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis publication-title: Clin. Gastroenterol. Hepatol. – volume: 308 start-page: 267 year: 1992 end-page: 270 ident: bib0325 article-title: Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver publication-title: FEBS Lett. – volume: 46 start-page: 424 year: 2007 end-page: 429 ident: bib0300 article-title: The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis publication-title: Hepatology – volume: 86 start-page: 285 year: 2007 end-page: 300 ident: bib0095 article-title: Comparative review of diets for the metabolic syndrome, implications for nonalcoholic fatty liver disease publication-title: Am. J. Clin. Nutr. – volume: 130 start-page: 1617 year: 2006 end-page: 1624 ident: bib0215 article-title: The evolution of severe steatosis after bariatric surgery is related to insulin resistance publication-title: Gastroenterology – reference: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, executive summary. (1998) Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. – volume: 47 start-page: 135 year: 2007 end-page: 141 ident: bib0480 article-title: Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes, a histopathological follow-up study publication-title: J. Hepatol. – volume: 362 start-page: 1675 year: 2010 end-page: 1685 ident: bib0240 article-title: NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis publication-title: N. Engl. J. Med – volume: 52 start-page: 2387 year: 2007 end-page: 2395 ident: bib0380 article-title: The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease, a pilot study publication-title: Dig Dis. Sci. – volume: 100 start-page: 1082 year: 2005 end-page: 1090 ident: bib0270 article-title: A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease publication-title: Am. J. Gastroenterol. – volume: 39 start-page: 770 year: 2004 end-page: 778 ident: bib0395 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial publication-title: Hepatology – volume: 7 start-page: 481 year: 2009 end-page: 486 ident: bib0050 article-title: Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease publication-title: Clin. Gastroenterol. Hepatol. – volume: 14 start-page: 1598 year: 2008 end-page: 1602 ident: bib0120 article-title: Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children publication-title: World J. Gastroenterol. – volume: 21 start-page: 191 year: 2006 end-page: 198 ident: bib0125 article-title: Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis publication-title: J. Gastroenterol. Hepatol. – volume: 101 start-page: 2790 year: 1998 end-page: 2799 ident: bib0385 article-title: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation publication-title: J. Clin. Invest. – volume: 58 start-page: 1281 year: 2009 end-page: 1288 ident: bib0105 article-title: High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease publication-title: Gut. – volume: 16 start-page: 1014 year: 1992 end-page: 1021 ident: bib0320 article-title: Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis publication-title: Hepatology – volume: 51 start-page: 121 year: 2010 end-page: 129 ident: bib0100 article-title: Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis publication-title: Hepatology – reference: Ratziu V., – reference: 115, 956–61. – volume: 93 start-page: 139 year: 1998 end-page: 143 ident: bib0375 article-title: Milk thistle (Silybum marianum) for the therapy of liver disease publication-title: Am. J. Gastroenterol. – volume: 4 start-page: 165 year: 1998 end-page: 178 ident: bib0390 article-title: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production publication-title: Mol. Med. – volume: 24 start-page: 1553 year: 2006 end-page: 1561 ident: bib0115 article-title: Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease publication-title: Aliment Pharmacol. Ther. – volume: 14 start-page: 47 year: 2004 end-page: 53 ident: bib0225 article-title: Results of laparoscopic gastric bypass in patients with cirrhosis publication-title: Obes. Surg. – volume: 16 start-page: 607 year: 2006 end-page: 611 ident: bib0210 article-title: Histological findings in the liver before and after gastric bypass publication-title: Obes. Surg. – reference: Perelas A., – volume: 51 start-page: 445 year: 2010 end-page: 453 ident: bib0260 article-title: Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial publication-title: Hepatology – volume: 17 start-page: 486 year: 2007 end-page: 492 ident: bib0200 article-title: Resolution of nonalcoholic steatohepatits after gastric bypass surgery publication-title: Obes. Surg. – volume: 51 start-page: 371 year: 2009 end-page: 379 ident: bib0055 article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis publication-title: J. Hepatol. – volume: 360 start-page: 859 year: 2009 end-page: 873 ident: bib0175 article-title: Comparison of weight-loss diets with different compositions of fat., protein., and carbohydrates publication-title: N. Engl. J. Med. – volume: 22 start-page: 634 year: 2007 end-page: 638 ident: bib0430 article-title: Beneficial effects of pentoxifylline on hepatic steatosis., fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis publication-title: J. Gastroenterol. Hepatol. – volume: 116 start-page: 1413 year: 1999 end-page: 1419 ident: bib0020 article-title: Nonalcoholic fatty liver disease, a spectrum of clinical and pathological severity publication-title: Gastroenterology – volume: 118 start-page: 3160 year: 2008 end-page: 3169 ident: bib0460 article-title: Hepatic CB1 receptor is required for development of diet-induced steatosis., dyslipidemia., and insulin and leptin resistance in mice publication-title: J. Clin. Invest. – volume: 19 start-page: 537 year: 2004 end-page: 544 ident: bib0280 article-title: Metformin in the treatment of patients with non-alcoholicsteatohepatitis publication-title: Aliment Pharmacol. Ther. – volume: 41 start-page: 1313 year: 2005 end-page: 1321 ident: bib0040 article-title: Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: Hepatology – volume: 99 start-page: 2365 year: 2004 end-page: 2368 ident: bib0425 article-title: A pilot trial of pentoxifylline in nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. – reference: NIH conference. (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. – reference: J – volume: 7 start-page: 678 year: 2008 end-page: 693 ident: bib0405 article-title: Targeting bile-acid signalling for metabolic diseases publication-title: Nat. Rev. Drug. Discov. – volume: 10 start-page: 414 year: 1995 ident: 10.1016/j.tem.2010.08.003_bib0160 article-title: Effect of weight control on hepatic abnormalities in obese patients with fatty liver publication-title: J. Korean Med. Sci. doi: 10.3346/jkms.1995.10.6.414 – volume: 351 start-page: 1106 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0490 article-title: Thiazolidinediones publication-title: N Engl J Med. doi: 10.1056/NEJMra041001 – volume: 41 start-page: 1313 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0040 article-title: Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.20701 – volume: 7 start-page: 363 year: 2001 ident: 10.1016/j.tem.2010.08.003_bib0060 article-title: Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis publication-title: Liver Transpl. doi: 10.1053/jlts.2001.23011 – volume: 39 start-page: 770 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0395 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial publication-title: Hepatology doi: 10.1002/hep.20092 – volume: 93 start-page: 139 year: 1998 ident: 10.1016/j.tem.2010.08.003_bib0375 article-title: Milk thistle (Silybum marianum) for the therapy of liver disease publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.1998.00139.x – volume: 47 start-page: 135 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0480 article-title: Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes, a histopathological follow-up study publication-title: J. Hepatol. doi: 10.1016/j.jhep.2007.02.013 – volume: 43 start-page: 1060 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0135 article-title: Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2005.06.008 – volume: 51 start-page: 373 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0015 article-title: Long-term mortality in nonalcoholic fatty liver disease, is liver histology of any prognostic significance? publication-title: Hepatology doi: 10.1002/hep.23521 – volume: 46 start-page: 424 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0300 article-title: The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.21661 – volume: 39 start-page: 1647 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0195 article-title: Nonalcoholic fatty liver disease. Improvement in liver histological analysis with weight loss publication-title: Hepatology doi: 10.1002/hep.20251 – ident: 10.1016/j.tem.2010.08.003_bib0400 doi: 10.1016/S0016-5085(09)63900-7 – volume: 16 start-page: 607 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0210 article-title: Histological findings in the liver before and after gastric bypass publication-title: Obes. Surg. doi: 10.1381/096089206776944904 – volume: 38 start-page: 48 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0145 article-title: Vitamin E treatment in pediatric obesity-related liver disease, a randomized study publication-title: J. Pediatr. Gastroenterol. Nutr. doi: 10.1097/00005176-200401000-00012 – volume: 360 start-page: 859 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0175 article-title: Comparison of weight-loss diets with different compositions of fat., protein., and carbohydrates publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0804748 – volume: 49 start-page: 1563 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0165 article-title: Hepatic decompensation after gastric bypass surgery for severe obesity publication-title: Dig Dis. Sci. doi: 10.1023/B:DDAS.0000043364.75898.c8 – volume: 40 start-page: 1222 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0440 article-title: Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.20420 – volume: 100 start-page: 1082 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0270 article-title: A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2005.41583.x – volume: 14 start-page: 1598 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0120 article-title: Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children publication-title: World J. Gastroenterol. doi: 10.3748/wjg.14.1598 – volume: 22 start-page: 2082 issue: 348 year: 2003 ident: 10.1016/j.tem.2010.08.003_bib0170 article-title: A randomized trial of a low-carbohydrate diet for obesity publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa022207 – volume: 27 start-page: 103 year: 1997 ident: 10.1016/j.tem.2010.08.003_bib0155 article-title: Therapeutic effects of restricted diet and exercise in obese patients with fatty liver publication-title: J. Hepatol. doi: 10.1016/S0168-8278(97)80287-5 – volume: 50 start-page: 1818 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0370 article-title: Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial publication-title: Hepatology doi: 10.1002/hep.23239 – volume: 9 start-page: 63 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0010 article-title: Impact of non-alcoholic fatty liver disease on accelerated metabolic complications publication-title: J. Dig Dis. doi: 10.1111/j.1751-2980.2008.00323.x – volume: 46 start-page: 113 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0250 article-title: The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease publication-title: Acta. Diabetol. doi: 10.1007/s00592-008-0067-2 – volume: 99 start-page: 2365 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0425 article-title: A pilot trial of pentoxifylline in nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2004.40064.x – volume: 4 start-page: 1537 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0335 article-title: Swiss Association for the Study of the Liver. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2006.09.025 – volume: 251 start-page: 2241 year: 1984 ident: 10.1016/j.tem.2010.08.003_bib0470 article-title: Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man publication-title: JAMA doi: 10.1001/jama.1984.03340410049031 – volume: 100 start-page: 1072 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0130 article-title: One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis, a pilot study publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2005.41334.x – volume: 142 start-page: 37 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0355 article-title: Meta-analysis, high-dosage vitamin E supplementation may increase all-cause mortality publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-142-1-200501040-00110 – volume: 114 start-page: 2788 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0485 article-title: Risks associated with statin therapy publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.624890 – volume: 13 start-page: 649 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0075 article-title: Lifestyle modification as the primary treatment of NASH publication-title: Clin. Liver Dis. doi: 10.1016/j.cld.2009.07.006 – volume: 34 start-page: 674 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0065 article-title: Non-invasive diagnosis of steatosis and fibrosis publication-title: Diabetes Metab doi: 10.1016/S1262-3636(08)74603-2 – volume: 17 start-page: 486 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0200 article-title: Resolution of nonalcoholic steatohepatits after gastric bypass surgery publication-title: Obes. Surg. doi: 10.1007/s11695-007-9086-2 – volume: 24 start-page: 1553 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0115 article-title: Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease publication-title: Aliment Pharmacol. Ther. doi: 10.1111/j.1365-2036.2006.03161.x – volume: 22 start-page: 18 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0245 article-title: Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/MEG.0b013e32832e2baf – volume: 16 start-page: 1014 year: 1992 ident: 10.1016/j.tem.2010.08.003_bib0320 article-title: Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis publication-title: Hepatology doi: 10.1002/hep.1840160426 – volume: 132 start-page: 2253 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0190 article-title: Bariatric surgery, a review of procedures and outcomes publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.057 – volume: 30 start-page: 1356 year: 1999 ident: 10.1016/j.tem.2010.08.003_bib0030 article-title: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.510300604 – volume: 51 start-page: 121 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0100 article-title: Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.23276 – volume: 308 start-page: 267 year: 1992 ident: 10.1016/j.tem.2010.08.003_bib0325 article-title: Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver publication-title: FEBS Lett. doi: 10.1016/0014-5793(92)81290-3 – volume: 31 start-page: 171 year: 1990 ident: 10.1016/j.tem.2010.08.003_bib0415 article-title: Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor publication-title: Circ. Shock – volume: 15 start-page: 1667 year: 2001 ident: 10.1016/j.tem.2010.08.003_bib0345 article-title: Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis, a pilot study publication-title: Aliment Pharmacol. Ther. doi: 10.1046/j.1365-2036.2001.01083.x – volume: 10 start-page: 166 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0070 article-title: Non-invasive diagnostic tests for non-alcoholic fatty liver disease publication-title: Curr. Mol. Med. doi: 10.2174/156652410790963321 – volume: 355 start-page: 2297 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0265 article-title: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa060326 – volume: 40 start-page: 1387 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0005 article-title: Prevalence of hepatic steatosis in an urban population in the United States, impact of ethnicity publication-title: Hepatology doi: 10.1002/hep.20466 – ident: 10.1016/j.tem.2010.08.003_bib0290 – volume: 21 start-page: 191 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0125 article-title: Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2005.04233.x – volume: 4 start-page: 165 year: 1998 ident: 10.1016/j.tem.2010.08.003_bib0390 article-title: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production publication-title: Mol. Med. doi: 10.1007/BF03401914 – volume: 3 start-page: 273 year: 2002 ident: 10.1016/j.tem.2010.08.003_bib0180 article-title: Physical activity and its impact on health outcomes. Paper 2. Prevention of unhealthy weight gain and obesity by physical activity, an analysis of the evidence publication-title: Obes. Rev. doi: 10.1046/j.1467-789X.2002.00078.x – volume: 135 start-page: 1176 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0255 article-title: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.06.047 – ident: 10.1016/j.tem.2010.08.003_bib0475 doi: 10.2174/157016110793563870 – volume: 293 start-page: G894 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0365 article-title: Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis publication-title: Am. J. Physiol. Gastrointest Liver Physiol. doi: 10.1152/ajpgi.00133.2007 – volume: 28 start-page: 220 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0410 article-title: Bile acids as regulators of hepatic lipid and glucose metabolism publication-title: Dig Dis. doi: 10.1159/000282091 – volume: 118 start-page: 3160 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0460 article-title: Hepatic CB1 receptor is required for development of diet-induced steatosis., dyslipidemia., and insulin and leptin resistance in mice publication-title: J. Clin. Invest. doi: 10.1172/JCI34827 – volume: 123 start-page: S19 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0305 article-title: Effects of incretin hormones on beta-cell mass and function, body weight., and hepatic and myocardial function publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2009.12.006 – volume: 116 start-page: 1413 year: 1999 ident: 10.1016/j.tem.2010.08.003_bib0020 article-title: Nonalcoholic fatty liver disease, a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 99 start-page: 1946 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0420 article-title: Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical., biochemical., and metabolic parameters of patients with nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2004.40220.x – volume: 38 start-page: 413 year: 2003 ident: 10.1016/j.tem.2010.08.003_bib0150 article-title: Cytokines and NASH, a pilot study of the effects of lifestyle modification and vitamin E publication-title: Hepatology doi: 10.1053/jhep.2003.50316 – volume: 86 start-page: 285 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0095 article-title: Comparative review of diets for the metabolic syndrome, implications for nonalcoholic fatty liver disease publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/86.2.285 – volume: 113 start-page: 898 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0080 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.171016 – volume: 98 start-page: 2485 year: 2003 ident: 10.1016/j.tem.2010.08.003_bib0340 article-title: Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2003.08699.x – volume: 28 start-page: 386 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0025 article-title: Diagnosis of nonalcoholic fatty liver disease, invasive versus noninvasive publication-title: Semin. Liver Dis. doi: 10.1055/s-0028-1091983 – volume: 51 start-page: 371 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0055 article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2009.03.019 – volume: 71 start-page: 551 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0110 article-title: Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease publication-title: J. Chin. Med. Assoc. doi: 10.1016/S1726-4901(08)70168-0 – volume: 101 start-page: 368 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0205 article-title: Non-alcoholic steatohepatitis, effect of Roux-en-Y gastric bypass surgery publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2006.00419.x – volume: 19 start-page: 537 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0280 article-title: Metformin in the treatment of patients with non-alcoholicsteatohepatitis publication-title: Aliment Pharmacol. Ther. doi: 10.1111/j.1365-2036.2004.01888.x – ident: 10.1016/j.tem.2010.08.003_bib0090 – volume: 25 start-page: 1141 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0435 article-title: Angiotensin receptor blockers in the treatment of NASH/NAFLD, could they be a first-class option? Adv publication-title: Ther. – volume: 51 start-page: 445 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0260 article-title: Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial publication-title: Hepatology doi: 10.1002/hep.23270 – volume: 22 start-page: 634 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0430 article-title: Beneficial effects of pentoxifylline on hepatic steatosis., fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2006.04756.x – volume: 108 start-page: 1167 year: 2001 ident: 10.1016/j.tem.2010.08.003_bib0285 article-title: Role of AMP-activated protein kinase in mechanism of metformin action publication-title: J. Clin. Invest. doi: 10.1172/JCI13505 – volume: 7 start-page: 481 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0050 article-title: Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2008.12.015 – volume: 128 start-page: 1898 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0045 article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.03.084 – volume: 283 start-page: 33021 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0455 article-title: Endocannabinoids and the control of energy homeostasis publication-title: J. Biol. Chem. doi: 10.1074/jbc.R800012200 – volume: 2 start-page: 1107 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0275 article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/S1542-3565(04)00457-4 – volume: 52 start-page: 2387 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0380 article-title: The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease, a pilot study publication-title: Dig Dis. Sci. doi: 10.1007/s10620-006-9703-2 – volume: 101 start-page: 2790 year: 1998 ident: 10.1016/j.tem.2010.08.003_bib0385 article-title: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation publication-title: J. Clin. Invest. doi: 10.1172/JCI1325 – volume: 7 start-page: 678 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0405 article-title: Targeting bile-acid signalling for metabolic diseases publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd2619 – volume: 16 start-page: 39 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0500 article-title: Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study publication-title: J Gastrointestin Liver Dis. – volume: 57 start-page: 445 year: 2005 ident: 10.1016/j.tem.2010.08.003_bib0465 article-title: Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease publication-title: Pediatr. Res. doi: 10.1203/01.PDR.0000153672.43030.75 – volume: 58 start-page: 1281 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0105 article-title: High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease publication-title: Gut. doi: 10.1136/gut.2008.151977 – volume: 136 start-page: 734 year: 2000 ident: 10.1016/j.tem.2010.08.003_bib0350 article-title: Vitamin E treatment of nonalcoholic steatohepatitis in children, a pilot study publication-title: J Pediatr. doi: 10.1016/S0022-3476(00)05040-X – volume: 53 start-page: 413 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0140 article-title: Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase., fasting insulin., and quality of life publication-title: Gut. doi: 10.1136/gut.2003.027581 – volume: 37 start-page: 229 year: 2007 ident: 10.1016/j.tem.2010.08.003_bib0330 article-title: Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis, results of a pilot study publication-title: Intern. Med. J. doi: 10.1111/j.1445-5994.2006.01295.x – volume: 14 start-page: 47 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0225 article-title: Results of laparoscopic gastric bypass in patients with cirrhosis publication-title: Obes. Surg. doi: 10.1381/096089204772787284 – ident: 10.1016/j.tem.2010.08.003_bib0085 doi: 10.1016/j.jada.2007.05.009 – volume: 135 start-page: 48 year: 2004 ident: 10.1016/j.tem.2010.08.003_bib0235 article-title: Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis publication-title: Surgery doi: 10.1016/j.surg.2003.10.003 – volume: 15 start-page: 942 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0450 article-title: Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis publication-title: World J. Gastroenterol. doi: 10.3748/wjg.15.942 – volume: 362 start-page: 1675 year: 2010 ident: 10.1016/j.tem.2010.08.003_bib0240 article-title: NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa0907929 – volume: 24 start-page: 275 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0315 article-title: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years publication-title: Curr. Med. Res. Opin. doi: 10.1185/030079908X253870 – ident: 10.1016/j.tem.2010.08.003_bib0185 doi: 10.7326/0003-4819-115-12-956 – volume: 49 start-page: 809 year: 2009 ident: 10.1016/j.tem.2010.08.003_bib0035 article-title: Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD), a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network publication-title: Hepatology doi: 10.1002/hep.22724 – ident: 10.1016/j.tem.2010.08.003_bib0220 doi: 10.1002/14651858.CD007340.pub2 – volume: 130 start-page: 1617 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0215 article-title: The evolution of severe steatosis after bariatric surgery is related to insulin resistance publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.024 – volume: 133 start-page: 84 year: 1998 ident: 10.1016/j.tem.2010.08.003_bib0230 article-title: Unsuspected cirrhosis discovered during elective obesity operations publication-title: Arch. Surg. doi: 10.1001/archsurg.133.1.84 – volume: 73 start-page: 382 year: 2006 ident: 10.1016/j.tem.2010.08.003_bib0495 article-title: New therapies for type 2 diabetes based on glucagon-like peptide 1 publication-title: Cleve Clin J Med. doi: 10.3949/ccjm.73.4.382 – volume: 300 start-page: 2123 year: 2008 ident: 10.1016/j.tem.2010.08.003_bib0360 article-title: Vitamins E and C in the prevention of cardiovascular disease in men, the Physicians’ Health Study II randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2008.600 |
| SSID | ssj0014815 |
| Score | 2.1974516 |
| SecondaryResourceType | review_article |
| Snippet | Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in the Western world. It can lead to cirrhosis and hepatocellular cancer,... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 668 |
| SubjectTerms | Animals Biological and medical sciences Biopsy - methods Clinical Trials as Topic - trends Endocrinology & Metabolism Fatty Liver - diagnosis Fatty Liver - pathology Fatty Liver - therapy Fundamental and applied biological sciences. Psychology Humans Life Style Non-alcoholic Fatty Liver Disease Patient Selection Prognosis Therapies, Investigational - methods Treatment Outcome Vertebrates: endocrinology |
| Title | Novel treatment modalities for nonalcoholic steatohepatitis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1043276010001335 https://www.clinicalkey.es/playcontent/1-s2.0-S1043276010001335 https://dx.doi.org/10.1016/j.tem.2010.08.003 https://www.ncbi.nlm.nih.gov/pubmed/20880717 https://www.proquest.com/docview/762031240 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5sBRFEfFsfJQdPQmyyu9kGPIkoVbEXFXpbspstVrQtJnr0tzuTbCJFq-A1ZDbJZB7fx87OABylmEU5eVoUGOlTTyk_IbISMeqLiYCiG9Dh5Nu-7D2I60E0WIDz6iwMlVW62F_G9CJauysdp83OdDTq3IXUTY5KOgocw6MGLDLM9nETFs-ubnr9ejOB-pGUTQm4TwLV5mZR5pXbF1fgRUWVfF56WpkmGSptWE67mA9Hi7R0uQarDk96Z-Urr8OCHW_A0q3bMd-E0_7k3T57dT259zJJCXojQfYQr3pjQuLFlNyR8eiP55NHS1XW-SjbgofLi_vznu8GJvgGeUfuIxWRQSpSkyIL0UPLgsQGYSosgg4rDbcW-UiKCC42OhRa6EgmhiUyRhpoTCz4NjTxsXYXPC3S2AyNEBoXFF10c2PkkEuhteGxZS0IKj0p47qJ01CLZ1WVjT0pVK0i1SoadBnwFhzXItOylcZvN7NK-ao6I4pRTWGg_02o-5OQzZxfZipUGVOB-mY7LRC15Iz5_fXA9oxd1N_FkPkzIXFdrzIUhX5LmzHJ2E7eMoVJCOMp4qkW7JQG9CWMkZ9o9t7_XmoflosSh-LA5AE089c3e4jIKddtaJx8hG3nH5_jdxRG |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB60ggoivq2PmoMnITTNbrYBT1KUVm0vttDbkt1ssVLbYqK_35lkEylaBa-hk8d0Zvb72G9nAC5jXEUZZVrgaeFSTyk3IrIS-NQXEwFF06PDyd2eaA_4_TAYrkCrOAtDskpb-_OanlVre6VuvVmfj8f1pwZ1kyNJR4ZjWLAKa5yGWldg7abz0O6VmwnUjyRvSsBcMig2NzOZV2percCLRJVs2fK0NY8SdNoon3axHI5my9LdDmxbPOnc5K-8CytmugfrXbtjvg_XvdmHmTilntx5ncUEvZEgO4hXnSkh8WxK7lg79I-ns2dDKut0nBzA4O6232q7dmCCq5F3pC5SEeHFPNYxshA1Mr4XGa8Rc4OgwwjNjEE-EiOCC7VqcMVVICLtRyJEGqh1yNkhVPCx5hgcxeNQjzTnCm_Im5jmWosRE1wpzULjV8Er_CS17SZOQy0mspCNvUh0rSTXShp06bEqXJUm87yVxm8_9gvny-KMKFY1iYX-N6PmT0YmsXmZyIZMfOnJb7FTBV5aLoTfXw-sLcRF-V0-Mn-fC7yvUwSKxLylzZhoambvicRFCOsp4qkqHOUB9GWMlZ9o9sn_XuoCNtr97qN87PQeTmEzkztkhyfPoJK-vZtzRFGpqtks-QRjXhYs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+treatment+modalities+for+nonalcoholic+steatohepatitis&rft.jtitle=Trends+in+endocrinology+and+metabolism&rft.au=Satapathy%2C+Sanjaya+K.&rft.au=Sanyal%2C+Arun+J&rft.date=2010-11-01&rft.issn=1043-2760&rft.volume=21&rft.issue=11&rft.spage=668&rft.epage=675&rft_id=info:doi/10.1016%2Fj.tem.2010.08.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_tem_2010_08_003 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10432760%2FS1043276010X0011X%2Fcov150h.gif |